Target Name: SRD5A1P1
NCBI ID: G6719
Other Name(s): Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1) pseudogene | Steroid-5-alpha-reductase, alpha polypeptide pseudogene 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha pseudogene) | steroid 5 alpha-reductase 1 pseudogene 1 | SRD5AP1 | Steroid-5-alpha-reductase 1 pseudogene | Steroid 5 alpha-reductase 1 pseudogene 1 | Steroid 5 alpha-reductase A1 pseudogene 1 | Steroid-5-alpha-reductase, alpha polypeptide 1 pseudogene 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha pseudogene)

SRD5A1P1: A Potential Drug Target and Biomarker

SRD5A1P1, also known asalpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1), is a gene that encodes a protein involved in the production of androsterone, which is a natural hormone that plays a crucial role in various physiological processes in the body. The gene has been identified as a potential drug target and biomarker for several diseases, includingandrogen-dependent diseases andandrogen-independent diseases.

The SRD5A1P1 gene was first identified in the late 1990s using DNA sequencing techniques. The gene is located on chromosome 16 and encodes a protein with 1,942 amino acid residues. The protein is involved in the conversion of androgens, such as androstenedione and androsterone, to androsterone.

One of the unique features of SRD5A1P1 is its role in androgen production and regulation. Androgens are produced by the testes and other tissues in the body, and they play a vital role in the development and maintenance of male characteristics, such as the growth of facial hair, the development of muscle mass, and the regulation of bone density. Androgens are regulated by a complex system of enzymes, including the 3-beta-hydroxysteroid dehydrogenase (3-beta-HSD) enzymes, which convert androgens to androsterone.

SRD5A1P1 is one of the key enzymes involved in this regulatory system. It is located in the nuclear envelope of the cell and is involved in the conversion of androgens to androsterone via a series of intermediate steps. The protein has been shown to interact with several other proteins involved in androgen production and regulation, including the androgen receptor (AR), which is a protein that plays a critical role in the regulation of androgen signaling.

The potential drug target for SRD5A1P1 is based on its involvement in androgen production and regulation. Androgens have been shown to have a variety of therapeutic potential for several diseases, including androgen-dependent diseases such as prostate cancer and androgen-independent diseases such as male pattern baldness and osteoporosis.

One of the key advantages of targeting SRD5A1P1 as a drug target is its potential to be a once-weekly therapy. Androgens are typically produced in response to daily hormonal fluctuations, and as a result, achieving constant levels of androgens can be challenging. By targeting SRD5A1P1, researchers hope to be able to reduce the frequency of treatment and improve the overall quality of life for patients.

Another potential advantage of targeting SRD5A1P1 is its potential to be a highly specific therapy. The androgen receptor is a protein that is expressed in many different tissues and cells, making it difficult to target with small molecules. By targeting SRD5A1P1, researchers hope to be able to more specifically target androgens and improve the effectiveness of any potential therapies.

In addition to its potential as a drug target, SRD5A1P1 has also been identified as a potential biomarker for several diseases. The androgen-dependent diseases, such as prostate cancer and androgen-independent diseases, are characterized by the production of high levels of androgens. By targeting SRD5A1P1, researchers hope to be able to diagnose and monitor these diseases more accurately and treat them more effectively.

In conclusion, SRD5A1P1 is a gene that encodes a protein involved in the production of androsterone, which is a natural hormone that plays a crucial role in various physiological processes

Protein Name: Steroid 5 Alpha-reductase 1 Pseudogene 1

More Common Targets

SRD5A2 | SRD5A3 | SRD5A3-AS1 | SREBF1 | SREBF2 | SREBF2-AS1 | SREK1 | SREK1IP1 | SRF | SRFBP1 | SRGAP1 | SRGAP2 | SRGAP2B | SRGAP2C | SRGAP2D | SRGAP3 | SRGN | SRI | SRI-AS1 | SRL | SRM | SRMS | SRP14 | SRP14-DT | SRP19 | SRP54 | SRP54-AS1 | SRP68 | SRP72 | SRP9 | SRP9P1 | SRPK1 | SRPK2 | SRPK3 | SRPRA | SRPRB | SRPX | SRPX2 | SRR | SRRD | SRRM1 | SRRM1P1 | SRRM2 | SRRM2-AS1 | SRRM3 | SRRM4 | SRRM5 | SRRT | SRSF1 | SRSF10 | SRSF11 | SRSF12 | SRSF2 | SRSF3 | SRSF3P2 | SRSF4 | SRSF5 | SRSF6 | SRSF6P1 | SRSF7 | SRSF8 | SRSF9 | SRXN1 | SRY | SS18 | SS18L1 | SS18L2 | SSB | SSBP1 | SSBP2 | SSBP3 | SSBP3-AS1 | SSBP3P2 | SSBP4 | SSC4D | SSC5D | SSH1 | SSH2 | SSH3 | SSMEM1 | SSNA1 | SSPN | SSPOP | SSR1 | SSR1P2 | SSR2 | SSR3 | SSR4 | SSR4P1 | SSRP1 | SST | SSTR1 | SSTR2 | SSTR3 | SSTR4 | SSTR5 | SSTR5-AS1 | SSU72 | SSU72L2 | SSU72P1